Ideaya Biosciences, Inc. (IDYA) — 10-Q Filings
All 10-Q filings from Ideaya Biosciences, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
IDEAYA Swings to Profit on Collaboration Revenue Surge
— Nov 4, 2025 Risk: medium
IDEAYA Biosciences, Inc. reported a significant turnaround in its financial performance for the three months ended September 30, 2025, achieving a net income of -
IDEAYA's Q2 Loss Widens Amid R&D Surge, Revenue Dip
— Aug 5, 2025 Risk: high
IDEAYA Biosciences, Inc. reported a net loss of $49.7 million for the three months ended June 30, 2025, an increase from a net loss of $40.1 million for the sam -
IDEAYA Biosciences Q1 2025 Update
— May 6, 2025 Risk: medium
IDEAYA Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position and business activities, including -
IDEAYA Biosciences Q3 2024 Update
— Nov 4, 2024 Risk: medium
IDEAYA Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its Werner Helicase Program and its San Diego, Califor -
IDEAYA Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: medium
IDEAYA Biosciences, Inc. (IDYA) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. IDEAYA Biosciences, Inc. reported its Q1 2024 financial results on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX